Back to
Parallax Volatility Advisers, L.P.
MCRB
7 quarters
Position history for
Parallax Volatility Advisers, L.P.'s holdings in Seres Therapeutics, Inc.
No. Parallax Volatility Advisers exited its MCRB (Seres Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 43,163 shares worth $60,428. Parallax Volatility Advisers first reported MCRB in Q2 2022 and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$343,000
Total Shares Change
-100,000
Quarter-by-Quarter History
Other major holders of MCRB: ARK Investment Management LLC, FMR LLC